INPLASY202660011

Subcutaneous Tirzepatide Versus Semaglutide and Emerging Incretin Agents in Type 2 Diabetes: A Comprehensive Frequentist Network Meta-Analysis of 42 Trials Through May 2026

Keywords: tirzepatide; semaglutide; network meta-analysis; incretin; GLP-1; GIP; type 2 diabetes; HbA1c; body weight; SUCRA; SURMOUNT-5.

Read and download full-text here - PDF 202660011

Review Status: ongoing